Furthermore, we have shown that treatment with cisplatin increases CD44-positive bladder cancer cells expressing Oct4, representing cancer stem-like cell subpopulation, which contributes to drug resistance and tumor recurrence [13]. This evidence concerns the gene POU5F1 and neoplasm.